Download PDF - Edinburgh Bioquarter

Contact usp01locate at BioQuarterthe quarterly newsletter from Edinburgh BioQuarter Issue 01 Winter 2011W: www.edinburghbioquarter.com T: 0131 242 9249 E: james.wood@bioquarter.comMore about EdinburghOpen for Business!Welcome to ourfirst quarterlynewsletter. I’venow been atBioQuarter foreight monthsand I think we’vehit a few earlytargets. In thearticles on thispage you’ll find out more about thenew biotechnology companies we’relaunching this month, the innovationcompetition we launched threeweeks ago and progress on our newbio-incubator building, which will beready for occupancy in mid-2011.We also welcome Dr Diane Harbisonas our new Head of BusinessDevelopment from Pfizer this month,and we’re pleased to announce thelaunch of a revamped BioQuarterwebsite. For more detail on any of thearticles in this update, just click on theweblink at the end of each article.As always, we welcome anycomments you might have atthe address above.Mike CapaldiCommercialisation DirectorEdinburgh BioQuarterQueens’ Medical Research Institute,47 Little France Crescent,EdinburghEH16 4TJFirst spin-out companies revealedEdinburgh BioQuarter announces itsfirst spin-outs this month, with theophthalmic diagnostics company i2eyebeing launched, as well as managementconsultancy NeuroORG.Incorporated in October 2010, i2eye hascreated a new ophthalmic diagnosticsdevice based on intellectual propertydeveloped at the University of Edinburgh.i2eye’s device provides a reliable test forlateral sight performance in those patientsold and very young for whom traditionalsight tests are confusing.Incorporating in November 2010, NeuroORGis an innovative management consultancythat engineers organisational performanceand design from the perspective of the humanbrain’s function with different organs, reducingmanagement engagement in organisationalprocesses that are intuitive, in the same wayas the body reacts to certain stimuli withoutreference to the brain. Its goal is to makeorganisations more efficient in their designand performance.Dr Mike Finnen, Head of Operations atEdinburgh BioQuarter, said: “We’re pleased tolead off our commercialisation work with thesetwo promising start-ups. Both companies havealready identified potential customers andhave clear business plans in place, with i2eyeestimating that they have a total addressablemarket of more than US$280 million.NeuroORG has already had expressionsof interest in its services from leadinginternational companies based in the UK, andwe’re confident that both organisations willhave positive revenue accruing within the firstyear of formation. Without BioQuarter funding,there’s no doubt these companies would nothave come into existence.”We’re pleasedto lead off ourcommercialisationwork with these twopromising start-upsLOOKING AHEADi2eye Diagnostics willoffer a brand new visualfield analyser for patientspreviously impossible to testFor more information about i2eyeLtd or NeuroORG Ltd, contact DrMike Finnen at:e: michael.finnen@bioquarter.comt: +44 (0) 131 242 9248New Headof BusinessDevelopmentat BioQuarterDiane Harbison has joined us fromPfizer Ltd as our new Head of BusinessDevelopment. Diane spent the last tenyears at Pfizer, latterly as a member of theGlobal R&D business development team.Diane was Global Business Developmentleader for Pfizer’s Regenerative MedicineGroup, and was the lead negotiator intheir groundbreaking R&D collaborationwith University College, London. She alsoled the acquisition of Axordia on behalf ofthe company. Prior to joining Pfizer, Dianewas part of the team working on the EMBLdatabase at the European Bio-informaticsInstitute. She began her career here inEdinburgh, working in the Kings Buildingson sex determination in fruit flies underProfessor Mary Bownes.Diane says, “BioQuarter representsa fantastic opportunity for me to dosomething creative and innovative basedon my previous experience in scienceand the pharmaceutical industry. Scotlandboasts a wealth of talent and qualityresearch in everything from clinicalmedicine through to informatics andengineering, and the chance to bringall of these different elements togetherin new companies that can make adifference is very attractive.”

Contact usp02locate at BioQuarterthe quarterly newsletter from Edinburgh BioQuarter Issue 01 Winter 2011W: www.edinburghbioquarter.com T: 0131 242 9249 E: james.wood@bioquarter.comMore about EdinburghBrand on the runNewBuildingin June2011BioQuarter has a new website and newpresentational materials. James Wood joinedus as Head of Communications in August2010, and since then he’s been busy updatingour web presence, press contacts and socialmedia. BioQuarter has been covered in TheTimes, The Herald, The Edinburgh EveningNews, Business7, Nihon Keizai Shimbun andThe Scotsman in recent weeks, and we hopeto expand this media profile further in themonths ahead.James said: “Making sure that investorsunderstand BioQuarter is one of the bestplaces in the world for new and establishedbiotech companies to do business is ournumber one message. Everything we doin terms of how we market and brand thisenvironment has to reflect the co-location ofoutstanding research talent, clinical excellenceand an experienced industrial team. I’mconfident that the plans we have in place for2011 will help us achieve these objectives.”Follow Edinburgh BioQuarter on Twitter:@EdinburghBQCheck out the new BioQuarter website:www.edinburghbioquarter.comor join our LinkedIn Group. Search for:LinkedIn ‘Edinburgh BioQuarter’New InnovationCompetition LaunchedThe new BioQuarter Incubator buildinghas broken ground and is progressing welltowards its initial completion date of June2011. The building will feature an incubatoron the ground floor which will house smallstart-up companies in a range of office andlab accommodation in a variety of suitesizes. There will be meeting rooms providedfor use by all tenants and a social/ informalnetworking area which will house a café,also serving the wider BioQuarter site.The two upper floors will provide flexibleaccommodation for office or laboratoryuse for more established companies.Jonathan Wilson, Project Manager at ScottishEnterprise, said: “Releasing 80,000 squarefeet of new accommodation at BioQuarterwill allow both start-up firms and internationalpharmaceutical companies the chance tolocate near three of the UK’s most significantmedical research institutes. Situated just afew hundred metres away from the RoyalInfirmary of Edinburgh, the Scottish Centrefor Regenerative Medicine and the Queens’Medical Research Institute, the building willprovide new and established firms with oneof the best co-location opportunitiesanywhere in the world.”For more information aboutthe new bio-incubator, go towww.edinburghbioquarter.com/officespace.phpOr contact Virginia Herriot atScottish Enterprise at:e: virginia.heriot@scotent.co.ukt: +44 (0) 131 313 6213BioQuarter launched its new ‘InnovationCompetition 2011’ on 8 November 2010 withthe slogan ‘Innovate and Win’ and, thanksto our sponsors, total prize money of morethan £55,000. Aimed at researchers basedin the NHS and University of Edinburgh, thiscompetition seeks to discover ideas for newcompanies in human and animal medicine.Prizes will be awarded in three rounds betweenApril and June 2011, with the overall winnerreceiving £10,000 to set up their own business.There are also awards worth a total of £15,000to recognise the best patent, best disclosureand best commercial idea from 2010.Dr David Newby, Director of Research atNHS Lothian, said: “Edinburgh BioQuarterhas the potential to become one of theworld’s leading medical research sitesand the innovation competition is a greatopportunity to inspire staff. It will encouragethem to develop their ideas and providethem with the financial investment theyneed to realise them.”More detail about the competitioncan be found at:www.innovateandwin.mvm.ed.ac.ukor by calling Lorraine Dobbs on:t: +44 (0) 131 242 9444